Why Africa must participate in Covid-19 vaccines trials

Illustrative picture of coronavirus vaccine under trail. [Courtesy, Standard]

Africa could benefit from lower prices by participating in the ongoing Covid-19 vaccine development efforts, experts have said.

There could also be cost trade-offs for countries taking part in vaccine trials because they are co-investors or partners in the projects, said Dr Borna Nyaoke-Anoke, manager, Clinical Trials at the Drugs for Neglected Diseases Initiative/Global Antibiotic Research and Development Partnership (DNDI/GARDP).